Real Time Insider Transaction Data
Real Time Insider buys and sells Data - Insider Trades - Insider Transactions - Insider Trading Data - SEC Form 4 Data
Total | Transactions | Amount |
Buys | 0 | $0 |
Sells | 21 | $10,228,203 |
Security | Reporting Name | Relationship | Purchase/Sale | Shares | Price $ | D/I | ||||
13 Jun 2024 18:06 | AKRO | Akero Therapeutics Inc | ROLPH TIMOTHY | Chief Scientific Officer | 11 Jun 2024 | Sale | 2,380 | 22.641 | 53,886 | D |
15 Mar 2024 16:42 | AKRO | Akero Therapeutics Inc | ROLPH TIMOTHY | Chief Scientific Officer | 13 Mar 2024 | Sale | 619 | 28.33 | 17,536 | D |
18 Dec 2023 20:29 | AKRO | Akero Therapeutics Inc | ROLPH TIMOTHY | Chief Scientific Officer | 14 Dec 2023 | Sale | 514 | 20.76 | 10,671 | D |
25 Sep 2023 20:30 | AKRO | Akero Therapeutics Inc | ROLPH TIMOTHY | Chief Scientific Officer | 13 Sep 2023 | Sale | 531 | 50.34 | 26,731 | D |
21 Jun 2023 17:46 | AKRO | Akero Therapeutics Inc | ROLPH TIMOTHY | Chief Scientific Officer | 16 Jun 2023 | Sale | 1,413 | 56.2966 | 79,547 | D |
21 Jun 2023 17:46 | AKRO | Akero Therapeutics Inc | ROLPH TIMOTHY | Chief Scientific Officer | 16 Jun 2023 | Sale | 27,462 | 55.08 | 1,512,607 | D |
21 Jun 2023 17:46 | AKRO | Akero Therapeutics Inc | ROLPH TIMOTHY | Chief Scientific Officer | 16 Jun 2023 | Sale | 49,325 | 54.575 | 2,691,912 | D |
15 Jun 2023 21:35 | AKRO | Akero Therapeutics Inc | ROLPH TIMOTHY | Chief Scientific Officer | 13 Jun 2023 | Sale | 509 | 55.16 | 28,076 | D |
30 Dec 2022 16:26 | AKRO | Akero Therapeutics Inc | ROLPH TIMOTHY | Chief Scientific Officer | 29 Dec 2022 | Sale | 12,293 | 51.3765 | 631,571 | D |
30 Dec 2022 16:26 | AKRO | Akero Therapeutics Inc | ROLPH TIMOTHY | Chief Scientific Officer | 29 Dec 2022 | Sale | 8,023 | 50.5481 | 405,547 | D |
30 Dec 2022 16:26 | AKRO | Akero Therapeutics Inc | ROLPH TIMOTHY | Chief Scientific Officer | 28 Dec 2022 | Sale | 1,700 | 50.0038 | 85,006 | D |
16 Nov 2022 19:15 | AKRO | Akero Therapeutics Inc | ROLPH TIMOTHY | Chief Scientific Officer | 16 Nov 2022 | Sale | 100 | 46.045 | 4,604 | D |
16 Nov 2022 19:15 | AKRO | Akero Therapeutics Inc | ROLPH TIMOTHY | Chief Scientific Officer | 16 Nov 2022 | Sale | 3,847 | 45.4534 | 174,859 | D |
16 Nov 2022 19:15 | AKRO | Akero Therapeutics Inc | ROLPH TIMOTHY | Chief Scientific Officer | 15 Nov 2022 | Sale | 3,138 | 45.0423 | 141,343 | D |
27 Oct 2022 21:27 | AKRO | Akero Therapeutics Inc | ROLPH TIMOTHY | Chief Scientific Officer | 26 Oct 2022 | Sale | 4,762 | 45.03 | 214,433 | D |
27 Oct 2022 21:27 | AKRO | Akero Therapeutics Inc | ROLPH TIMOTHY | Chief Scientific Officer | 25 Oct 2022 | Sale | 10,653 | 45.0905 | 480,349 | D |
27 Oct 2022 21:23 | AKRO | Akero Therapeutics Inc | ROLPH TIMOTHY | Chief Scientific Officer | 13 Sep 2022 | Sale A | 22,500 | 29.18 | 656,550 | D |
07 Oct 2022 18:00 | AKRO | Akero Therapeutics Inc | ROLPH TIMOTHY | Chief Scientific Officer | 06 Oct 2022 | Sale | 22,500 | 39.29 | 884,025 | D |
04 Oct 2022 20:57 | AKRO | Akero Therapeutics Inc | ROLPH TIMOTHY | Chief Scientific Officer | 30 Sep 2022 | Sale | 22,500 | 34.06 | 766,350 | D |
04 Oct 2022 20:57 | AKRO | Akero Therapeutics Inc | ROLPH TIMOTHY | Chief Scientific Officer | 30 Sep 2022 | Sale | 22,500 | 31.38 | 706,050 | D |
15 Sep 2022 19:56 | AKRO | Akero Therapeutics Inc | ROLPH TIMOTHY | Chief Scientific Officer | 13 Sep 2022 | Sale | 22,500 | 29.18 | 656,550 | D |
* D/I = Direct / Indirect
* 10% = Entity with 10% or higher ownership stake
* A = Amendment Filing (SEC Form 4/A)